none title certification

UAB "Pharmasanta group" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
111,026
23,522
368,844
-368,844
-78,145
22.38
-332.21
-1,447,111
12,820,340
11,022,262
350,531
2023
75,150
19,025
1,440,679
1,440,679
364,729
14.23
1,917.07
-6,432
11,264,332
10,918,240
339,603
2024
57,600
25,374
1,754,546
1,754,546
772,928
30.60
3,046.09
1,748,115
11,709,581
13,396,779
60,428
unlock data icon

Register and

explore Okredo data
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

57,600 €Descended-23 % *

Sales per employee (€)

25,374 €Ascended33 % *

Profit before tax (€)

1,754,546 €Ascended22 % *

Net Profit (€)

1,754,546 €Ascended22 % *

Profit per employee (€)

772,928 €Ascended112 % *

Total profitability (%)

30.60 %Ascended115.04 % *

Net profitability (%)

3,046.09 %Ascended58.89 % *

Equity (€)

1,748,115 €Ascended27,278 % *

Amounts Payable And Liabilities (€)

11,709,581 €Ascended4 % *

Non-current Assets (€)

13,396,779 €Ascended23 % *

CurrentAssets (€)

60,428 €Descended-82 % *

*over the last year starting selected period